Pemetrexed for diffuse malignant pleural mesothelioma

Conference proceeding

Peer reviewed

Christian MANEGOLD and Joseph AISNER

Seminars in oncology, Vol.29(2), pp.30-35

Pemetrexed, a Novel Multitargeted Antifolate: Current Development and Future Directions

2002

PMID: 12023790

Abstract

Biological and medical sciences

Chemotherapy

Medical sciences

Antineoplastic agents

Pharmacology. Drug treatments

10 Record Views

Title: Pemetrexed for diffuse malignant pleural mesothelioma
Creators: Christian MANEGOLD - Cancer Institute of New Jersey, Division of Oncology, Department of Medicine, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
Joseph AISNER - Cancer Institute of New Jersey, Division of Oncology, Department of Medicine, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
Publication Details: Seminars in oncology, Vol.29(2), pp.30-35
Conference: Pemetrexed, a Novel Multitargeted Antifolate: Current Development and Future Directions
Date published: 2002
Publisher: Elsevier
Academic Unit: Lung Cancer/Thoracic Oncology Program
Language: English
Resource Type: Conference proceeding
Identifiers: 991031653971104646